[HTML][HTML] Treatment of uncommon EGFR mutations in non-small cell lung cancer: new evidence and treatment
T Zhang, B Wan, Y Zhao, C Li, H Liu, T Lv… - … lung cancer research, 2019 - ncbi.nlm.nih.gov
Sensitizing mutations in epidermal growth factor receptor (EGFR) are associated with
positive responses to anti-EGFR-targeted therapy, leading to a new era of treatment for non …
positive responses to anti-EGFR-targeted therapy, leading to a new era of treatment for non …
[引用][C] Treatment of uncommon EGFR mutations in non-small cell lung cancer: new evidence and treatment
T Zhang, B Wan, Y Zhao, C Li, H Liu, T Lv… - … Lung Cancer Research, 2019 - cir.nii.ac.jp
Treatment of uncommon EGFR mutations in non-small cell lung cancer: new evidence and
treatment | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索 …
treatment | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索 …
Treatment of uncommon EGFR mutations in non-small cell lung cancer: new evidence and treatment
T Zhang, B Wan, Y Zhao, C Li, H Liu… - Translational lung …, 2019 - pubmed.ncbi.nlm.nih.gov
Sensitizing mutations in epidermal growth factor receptor (EGFR) are associated with
positive responses to anti-EGFR-targeted therapy, leading to a new era of treatment for non …
positive responses to anti-EGFR-targeted therapy, leading to a new era of treatment for non …
Treatment of uncommon EGFR mutations in non-small cell lung cancer: new evidence and treatment.
T Zhang, B Wan, Y Zhao, C Li, H Liu, T Lv… - Translational Lung …, 2019 - europepmc.org
Sensitizing mutations in epidermal growth factor receptor (EGFR) are associated with
positive responses to anti-EGFR-targeted therapy, leading to a new era of treatment for non …
positive responses to anti-EGFR-targeted therapy, leading to a new era of treatment for non …
[HTML][HTML] Treatment of uncommon EGFR mutations in non-small cell lung cancer: new evidence and treatment
T Zhang, B Wan, Y Zhao, C Li, H Liu, T Lv… - Translational Lung …, 2019 - tlcr.amegroups.org
Sensitizing mutations in epidermal growth factor receptor (EGFR) are associated with
positive responses to anti-EGFR-targeted therapy, leading to a new era of treatment for non …
positive responses to anti-EGFR-targeted therapy, leading to a new era of treatment for non …
[PDF][PDF] Treatment of uncommon EGFR mutations in non-small cell lung cancer: new evidence and treatment
T Zhang, B Wan, Y Zhao, C Li, H Liu, T Lv, P Zhan… - researchgate.net
Sensitizing mutations in epidermal growth factor receptor (EGFR) are associated with
positive responses to anti-EGFR-targeted therapy, leading to a new era of treatment for non …
positive responses to anti-EGFR-targeted therapy, leading to a new era of treatment for non …
[PDF][PDF] Treatment of uncommon EGFR mutations in non-small cell lung cancer: new evidence and treatment
T Zhang, B Wan, Y Zhao, C Li, H Liu, T Lv, P Zhan… - cdn.amegroups.cn
Sensitizing mutations in epidermal growth factor receptor (EGFR) are associated with
positive responses to anti-EGFR-targeted therapy, leading to a new era of treatment for non …
positive responses to anti-EGFR-targeted therapy, leading to a new era of treatment for non …
Treatment of uncommon EGFR mutations in non-small cell lung cancer: new evidence and treatment
T Zhang, B Wan, Y Zhao, C Li, H Liu, T Lv… - Translational Lung …, 2019 - tlcr.amegroups.org
Sensitizing mutations in epidermal growth factor receptor (EGFR) are associated with
positive responses to anti-EGFR-targeted therapy, leading to a new era of treatment for non …
positive responses to anti-EGFR-targeted therapy, leading to a new era of treatment for non …
Treatment of uncommon EGFR mutations in non-small cell lung cancer: new evidence and treatment.
T Zhang, B Wan, Y Zhao, C Li, H Liu, T Lv… - Translational Lung …, 2019 - europepmc.org
Sensitizing mutations in epidermal growth factor receptor (EGFR) are associated with
positive responses to anti-EGFR-targeted therapy, leading to a new era of treatment for non …
positive responses to anti-EGFR-targeted therapy, leading to a new era of treatment for non …